Symbol="VYGR"
AssetType="Common Stock"
Name="Voyager Therapeutics Inc"
Description="Voyager Therapeutics, Inc., a clinical-stage gene therapy company, is focused on developing treatments for patients with severe neurological diseases. The company is headquartered in Cambridge, Massachusetts."
CIK="1640266"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="75 SIDNEY STREET, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="448224000"
EBITDA="91673000"
PERatio="4.518"
PEGRatio="0"
BookValue="4.548"
DividendPerShare="0"
DividendYield="0"
EPS="2.26"
RevenuePerShareTTM="4.834"
ProfitMargin="0.492"
OperatingMarginTTM="0.448"
ReturnOnAssetsTTM="0.217"
ReturnOnEquityTTM="0.74"
RevenueTTM="194869000"
GrossProfitTTM="-19857000"
DilutedEPSTTM="2.26"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="5.82"
AnalystTargetPrice="13.67"
TrailingPE="4.518"
ForwardPE="-"
PriceToSalesRatioTTM="3.271"
PriceToBookRatio="2.825"
EVToRevenue="1.667"
EVToEBITDA="-8.56"
Beta="1.06"
num_52WeekHigh="14.34"
num_52WeekLow="4.77"
num_50DayMovingAverage="9.95"
num_200DayMovingAverage="8.62"
SharesOutstanding="43900500"
DividendDate="None"
ExDividendDate="None"
symbol="VYGR"
open="10.15"
high="10.30"
low="10.05"
price="10.23"
volume="235682.00"
latest_trading_day="2023-08-30"
previous_close="10.06"
change="0.17"
change_percent="1.6899%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="39"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="61"
Volume_recent_avg="525525"
Change_recent_avg="0.02"
Delta_recent_avg="0.58"
Variance_recent_avg="0.29"
Change_ratio_recent_avg="0.11"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="61"
Aroon_momentum_negative="39"
image_negative_thumbnail_id_1="170"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0006.jpeg"
image_negative_thumbnail_id_2="500"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0105.jpeg"
image_neutral_thumbnail_id_1="536"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0063.jpeg"
image_neutral_thumbnail_id_2="521"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0078.jpeg"
image_positive_thumbnail_id_1="619"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0089.jpeg"
image_positive_thumbnail_id_2="996"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0158.jpeg"
image_professor_thumbnail_id_1="1167"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0001.jpeg"
image_professor_thumbnail_id_2="1195"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
